• Find a Regulation
• Regulatory Activity
  • Actions Underway
  • Petitions
  • Legislative Mandates
  • Periodic Reviews
  • General Notices
• Meetings
• Guidance Documents
• Comment Forums

Description	Chapters 160 (Senate Bill 294) and 252 (House Bill 1161) of the Acts of Assembly (2012 regular session), requires all pharmacies and retailers in the Commonwealth of Virginia that sell over the counter cold and allergy medications containing ephedrine and/or pseudoephedrine products (PSE) to participate in a statewide, real-time electronic PSE monitoring program for the purpose of tracking illegal PSE purchases.
State Authority	Chapters 160 and 252 of the Act of Assembly (2012 regular session). § § 18.2-265.8 (C) and 18.2-265.12
Federal Authority	Combat Methamphetamine Epidemic Act of 2005 (CMEA)- Title VII of Public Law 109-177
Exempt from APA	No, changes to this chapter are subject to the Administrative Process Act.
Text of Regulation	Link to Virginia Administrative Code
Goals of Regulation	The purpose is to provide guidance for use of the a web-accessed database by approved law enforcement agencies. Pursuant to the Combat Methamphetamine Epidemic Act of 2005 (CMEA), pharmacies and retailers are currently required to capture certain data regarding ephedrine and/or pseudoephedrine products(PSE) sales. The system enables pharmacies to easily enter the same PSE sales data currently being gathered online rather than recording the information into a manual log or in-store computer system. Data will be stored in a secure, central repository that treats the data collected as if it were HIPAA data. Furthermore, the collected data will be viewable (at no cost) by authorized city, state, and federal law enforcement in keeping with CMEA, the Code of Virginia,and the Virginia Administrative Code.
Meetings